Form 4 for FBIO Fortress Biotech, Inc.
Accepted 2024-01-03 00:00:00 ET · period of report 2024-01-01 · accession 0001104659-24-000900 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-03 | 2024-01-01 | FBIO | WEISS MICHAEL S | See Remarks, Dir, 10% | A - Grant | $0.00 | +216.5K | 1.35M | +19% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK, PAR VALUE $0.001 | 2024-01-01 | A | A | 216,465 | $0.00 | 1,346,985 | D | — | — | (F1) The Reporting Person was granted 216,465 restricted shares pursuant to the Issuer's Long-Term Incentive Plan on January 1, 2024. |